Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,020
-13.31%
|
$286,840
$142.78 P/Share
|
|
Mar 05
2023
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,610
-4.58%
|
$228,620
$142.78 P/Share
|
|
Mar 05
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,882
-5.34%
|
$3,107,244
$142.78 P/Share
|
|
Mar 04
2023
|
Seamus Mulligan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+0.38%
|
$265,500
$59.13 P/Share
|
|
Mar 03
2023
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,373
+15.49%
|
-
|
|
Mar 03
2023
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,456
+18.21%
|
-
|
|
Mar 03
2023
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
12,447
+20.33%
|
-
|
|
Mar 03
2023
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,523
+22.98%
|
-
|
|
Mar 03
2023
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
12,784
+21.99%
|
-
|
|
Mar 03
2023
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,419
+20.62%
|
-
|
|
Mar 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,870
+20.32%
|
-
|
|
Mar 03
2023
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
10,429
+22.86%
|
-
|
|
Mar 03
2023
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,388
+9.38%
|
-
|
|
Feb 02
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$83,367
$157.26 P/Share
|
|
Feb 02
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Feb 01
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$155,000
$155.79 P/Share
|
|
Jan 03
2023
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.4%
|
$477,000
$159.79 P/Share
|
|
Jan 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$84,429
$159.59 P/Share
|
|
Jan 03
2023
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Dec 21
2022
|
Renee D Gala President & COO |
SELL
Open market or private sale
|
Direct |
2,635
-7.49%
|
$421,600
$160.0 P/Share
|
|
Dec 13
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$82,305
$155.45 P/Share
|
|
Dec 13
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Dec 09
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,844
-4.83%
|
$278,444
$151.54 P/Share
|
|
Dec 05
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
63
-1.05%
|
$9,576
$152.06 P/Share
|
|
Dec 05
2022
|
Daniel N Swisher Jr President and COO |
SELL
Other acquisition or disposition
|
Direct |
10,465
-18.22%
|
-
|
|
Dec 02
2022
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
420
-7.13%
|
$64,680
$154.68 P/Share
|
|
Dec 02
2022
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
420
-7.13%
|
$64,680
$154.68 P/Share
|
|
Dec 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.27%
|
$157,000
$157.0 P/Share
|
|
Nov 22
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Indirect |
2,000
-100.0%
|
$304,000
$152.88 P/Share
|
|
Nov 22
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
4,974
-10.91%
|
$741,126
$149.54 P/Share
|
|
Nov 16
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,510
-11.59%
|
$498,420
$142.34 P/Share
|
|
Nov 14
2022
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.0%
|
$29,353
$149.33 P/Share
|
|
Nov 10
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,063
-4.49%
|
$164,765
$155.0 P/Share
|
|
Nov 10
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,063
+4.3%
|
$115,867
$109.45 P/Share
|
|
Nov 10
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.53%
|
$300,000
$150.0 P/Share
|
|
Oct 03
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
45,185
-3.72%
|
$6,099,975
$135.0 P/Share
|
|
Oct 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
62,905
+13.05%
|
$3,711,395
$59.13 P/Share
|
|
Sep 07
2022
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
63
-0.32%
|
$9,450
$150.0 P/Share
|
|
Sep 06
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,703
-0.43%
|
$1,186,262
$154.03 P/Share
|
|
Sep 06
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.6%
|
$572,300
$59.13 P/Share
|
|
Sep 02
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$82,836
$156.98 P/Share
|
|
Sep 02
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Aug 18
2022
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
8,000
-35.98%
|
$1,264,000
$158.0 P/Share
|
|
Aug 18
2022
|
Peter Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+26.46%
|
$440,000
$55.28 P/Share
|
|
Aug 15
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,142
-13.77%
|
$338,436
$158.57 P/Share
|
|
Aug 15
2022
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+20.13%
|
$226,000
$113.1 P/Share
|
|
Aug 08
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
158
-2.53%
|
$24,016
$152.33 P/Share
|
|
Aug 08
2022
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
1,089
-15.6%
|
$165,528
$152.32 P/Share
|
|
Aug 08
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
1,089
-4.33%
|
$165,528
$152.33 P/Share
|
|
Aug 08
2022
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
1,179
-7.65%
|
$179,208
$152.32 P/Share
|